Paradigm raises $16m for phase III trial of knee osteoarthritis treatment
2024-12-09Stockhead
Paradigm receives firm commitments to raise $16 million through placement to institutional and sophisticated investors The funds will primarily support global phase III trial of iPPS to treat knee ...Read more